Trulieve Opening Medical Cannabis Dispensary in Evans, Georgia

Company celebrates grand opening and expands access to low-THC products for patients in the Augusta metropolitan area

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States announced the grand opening of a new medical cannabis dispensary located at 4218 Washington Road in Evans, GA.

The Evans dispensary will be Trulieve's fifth in the state, offering registered patients in Georgia's medical cannabis program products derived from low-THC oil, the only form of medical cannabis currently legal in Georgia . The location is Trulieve's first in northeast Georgia , giving patients in the greater Augusta area from Columbia , Richmond , Lincoln , and Burke counties better access to low-THC products.

"Our focus in Georgia is not only providing medical cannabis for registered patients but also to help educate people about the potential benefits for their specific conditions," said Trulieve's Chief Executive Officer Kim Rivers . "We're excited for the Evans location to serve as a venue for patient education and registration events as Georgia's medical cannabis program continues to grow."

A grand opening celebration begins at 10 a.m. on Saturday , Sept. 23 with a ribbon cutting, music, and merchandise giveaways. In addition to the grand opening, Dr. Krishna Doniparthi will be on-site providing information on the potential benefits of low-THC cannabis products and certifying patients with qualifying conditions for the Georgia Access to Medical Cannabis Program .

The Evans dispensary will be open 10 a.m. – 6 p.m. Tuesday through Saturday offering a wide range of top-quality, low-THC products under Trulieve's Momenta brand including nasal spray, tinctures, capsules, and topicals. Trulieve also offers several free resources on its website to help educate potential patients including its Find a Doctor tool, a free database of authorized physicians offering medical cannabis card evaluations in their area, and information on how to become a registered patient in Georgia .

To learn more, please visit Trulieve.com and connect on Instagram or Facebook .

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established hubs in the Northeast, Southeast, and Southwest, anchored by leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact
Christine Hersey , Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck , APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-opening-medical-cannabis-dispensary-in-evans-georgia-301935715.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2023/22/c9570.html

News Provided by Canada Newswire via QuoteMedia

TCNNF,TRUL:CNX
The Conversation (0)
Cannabis business with marijuana leaves and stock

Cannabis Market 2025 Year-End Review

2025 marked a turning point for investment in the cannabis sector, shifting the focus toward operational resilience and consolidation after a sluggish 2024. Key market drivers included an upswing in merger and acquisition (M&A) activity as stronger multi-state operators (MSOs) acquired... Keep Reading...
Cannabis plant with green leaves and buds on a dark green background.

Cannabis Market Forecast: Top Trends for Cannabis in 2026

The US cannabis market is entering 2026 with brighter prospects after a punishing few years marked by stalled rescheduling efforts, price compression, retail saturation and slow state expansion.Now, however, regulatory tailwinds seeming aligned for a potential re-rating.On December 18, US... Keep Reading...
Cannabis plant in focus, blurred US flag background.

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
Close-up of green cannabis leaves in natural light.

Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions

US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
Gavel on a surface with scattered cannabis leaves, symbolizing legal issues around marijuana.

Hemp THC Recriminalization: A Blow to a Blooming Industry

A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...

Interactive Chart

Latest Press Releases

Related News